REQUEST A DEMO
Total
USD $0.00
Search more companies

The Acme Laboratories Ltd (Bangladesh)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: The Acme Laboratories Ltd Profile Updated: August 22, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

The Acme Laboratories Ltd is engaged in the production of pharmaceutical products in Bangladesh. The company is currently producing more than 500 products in different dosage forms covering broader therapeutic categories which include anti-infective, cardiovascular, antidiabetics, gastrointestinal, CNS, respiratory disease etc. among many others.

Legal Address
Court De La Acme,1/4, Mirpur Road, Kallayanpur
Dhaka; Dhaka; Postal Code: 1207

Contact Details: Purchase the The Acme Laboratories Ltd report to view the information.

Website: http://www.acmeglobal.com

Basic Information
Total Employees:
Purchase the The Acme Laboratories Ltd report to view the information.
Outstanding Shares:
Purchase the The Acme Laboratories Ltd report to view the information.
Financial Auditors:
Purchase the The Acme Laboratories Ltd report to view the information.
Ratings:
Purchase the The Acme Laboratories Ltd report to view the information.
Incorporation Date:
1954
Key Executives
Purchase this report to view the information.
Chairman of the Board
Ownership Details
Purchase this report to view the information.
5.62%
Subsidiaries
Company Performance
Financial values in the chart are available after The Acme Laboratories Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BDT. Absolute financial data is included in the purchased report.
Net sales revenue
9.63%
Total operating revenue
10.08%
Operating profit (EBIT)
0.85%
EBITDA
9.17%
Net Profit (Loss) for the Period
4.63%
Total assets
8.13%
Total equity
5.24%
Operating Profit Margin (ROS)
-1.64%
Net Profit Margin
-0.37%
Return on Equity (ROE)
-0.03%
Debt to Equity Ratio
1.12%
Quick Ratio
-0%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?